China approves Gloria Biosciences' drug for cervical cancer treatment

Guangzhou Gloria Biosciences (GloriaBio), a commercial stage biopharmaceutical company focusing on the discovery, develo...

September 8, 2023 | Friday | News
Eminence opens new GMP cell culture media manufacturing facility in China

Eminence Biotechnology (Suzhou) Co. has announced that its state-of-the-art facility for the commercial production of ce...

September 7, 2023 | Thursday | News
Bristol Myers Squibb inks $50 M deal to treat immune-mediated diseases in Asia

US-based startup Zenas BioPharma has entered into a license and collaboration agreement with Bristol Myers Squibb Compan...

September 6, 2023 | Wednesday | News
Startups in China join forces to tackle challenges in brain health

China-based startups Infinite Brain Technologies (IBT) and ATLATL Innovation Centre (ATLATL) have entered a Memorandum o...

September 6, 2023 | Wednesday | News
Hong Kong publishes policy paper on university-industry collaboration for Chinese Medicine innovation

The Policy Research Centre for Innovation and Technology (PReCIT) and the Research Centre for Chinese Medicine Innovatio...

September 5, 2023 | Tuesday | News
Chinese startup HiRO acquires US-based CRO Courante Oncology, extends global footprint

China-based startup Harvest Integrated Research Organization (HiRO), an innovation global contract research organisation...

September 1, 2023 | Friday | News
Israel's Rapid Medical gains approval in China for world’s only adjustable thrombectomy device

Israel-based Rapid Medical, a leading developer of advanced neurovascular devices, has announced Chinese approval for it...

September 4, 2023 | Monday | News
Chinese startup Epigenic Therapeutics raises $32 M to strengthen work on epigenome medicine

Epigenic Therapeutics, a China-based biotechnology startup dedicated to developing next-generation gene modulation thera...

August 30, 2023 | Wednesday | News
How blood-based protein biomarkers enable early detection and intervention of Alzheimer’s disease

Alzheimer's disease (AD) is a rapidly growing global public health concern, with an estimated 55 million patients worldw...

September 1, 2023 | Friday | Opinion
XtalPi Inc. announces new automation facility in Shanghai for drug discovery

XtalPi Inc. (XtalPi), a leading technology platform company renowned for melding physics-based computation, artificial i...

August 29, 2023 | Tuesday | News
Hong Kong develops novel injectable hydrogel to revolutionise regenerative medicine

Researchers from the University of Hong Kong (HKU), the HKU-Shenzhen Hospital and the Princeton University, have collabo...

August 25, 2023 | Friday | News
China-based MGI partners with Korean startup NGeneBio to advance precision medicine

MGI, a China-based company committed to building core tools and technology to lead life scienc,e and South Korea based s...

August 23, 2023 | Wednesday | News
Mirxes inks new deals to scale adoption of early cancer detection solutions in APAC

Mirxes, a Singapore headquartered RNA technology company that is making diagnostic solutions for the early detection of ...

August 22, 2023 | Tuesday | News
Novo Holdings participates in $290 M strategic financing of China's Sangon Biotech

Novo Holdings, a leading international life science investor, has participated in a $290 million strategic financin...

August 21, 2023 | Monday | News
Global CRO Tigermed opens international headquarters in Hong Kong

Tigermed, a leading global Contract Research Organisation (CRO) providing integrated research and development solutions ...

August 18, 2023 | Friday | News
Hong Kong promotes development of advanced eye and vision research

The Centre for Eye and Vision Research (CEVR) and Aier Eye Hospital Group (Aier) have announced a strategic collaboratio...

August 16, 2023 | Wednesday | News
China's T-Maximum Biotech selects GenScript CRISPR reagents to target high-grade gliomas

US-based GenScript Biotech, and China-based startup T-Maximum Biotech, a biotechnology company pioneering universal...

August 10, 2023 | Thursday | News
China-based startup Zhejiang Innoforce Pharma names new CEO

China-based startup Zhejiang Innoforce Pharmaceuticals Co., a contract development and manufacturing organisation (CDMO)...

August 3, 2023 | Thursday | News